CTLA4 and neoplasm: An in situ transplantation model showed that inhibiting CHI3L1 reduced tumor growth and downregulated MAF and CTLA4, while BCSCs increased S100A4 levels, further supporting the role of TN-BCSCs in immune escape [288].